펜니들 시장 : 예측(2025-2030년)

The pen needle market is expected to grow at a CAGR of 9.27% over the forecast period to reach a total market size of US$3,189.012 million by 2030, increasing from US$2,046.792 million in 2025.

Pen needles are widely used to deliver injectable medication into the body. The rising prevalence of chronic disease is expected to be one of the prime drivers of market growth during the forecast period. However, the availability of substitutes is anticipated to restrain the market's growth in the coming years.

Pen Needle Market Drivers

• The growing prevalence of various chronic diseases is anticipated to drive the market in the forecasted period.

The rising prevalence of chronic diseases such as cancer and diabetes is one of the prime drivers for the market growth during the forecast period. According to the International Diabetes Federation report, the number of people with diabetes under the age group of 20-79 years has risen from 425 million in 2017 to 537 million in 2022 and is expected to reach 783 million in 2045.

In addition, the rising economic burden of diabetes and increasing healthcare expenditure worldwide are also anticipated to increase the demand for rapid diagnostic kits for glucose monitoring in the coming years. According to the International Diabetes Federation (IDF), global healthcare expenditure on diabetes was around USD 966 billion in 2022, representing an increase of 316% over the last 15 years.

According to the World Health Organization (WHO), in 2022, nearly 1.3 million people died from chronic hepatitis B and C infection, and approximately 254 million people lived with hepatitis B, and 50 million people are living with hepatitis C. The WHO, in its report, stated that in 2010, an estimated 524 million people were aged 65 or older, which constitutes 8 percent of the world's population, and by 2050 this number is expected to nearly triple to about 1.5 billion, representing 16% of the world population.

Poor nutrition, physical inactivity, and the harmful use of alcohol contribute to the development of chronic conditions like cardiovascular diseases, cancer, and chronic respiratory disease, which will directly affect the market for pen needles in the coming years.

North America holds a significant share of the market:

By geography, the pen needle market is segmented into North America, South America, Europe, the Middle East, Africa, and the Asia Pacific. The pen needle is fast gaining traction in North America due to the growing number of chronic disease cases. According to the United States Centre for Disease Control and Prevention, 6,08,336 people died due to cancer in the United States. The burgeoning need for a targeted drug delivery system that causes minimal side effects drives the demand for pen needles in the country.

Advancements in technology and increased healthcare spending have significantly boosted the pen needle market growth. For instance, U.S. healthcare spending increased by 4.1% to reach USD 4.5 trillion in 2022, as per the United States Centre for Medicare and Medicaid Services.

In Europe, the government is easing regulations and speeding up the approval process for innovative new drugs to meet the increasing needs of the aging population. This initiative aims to promote domestic and foreign pharmaceutical companies and attract new businesses to the European market.

In addition, increasing strategic investment by domestic market players in the form of mergers and acquisitions increases the competition, which is further expected to propel market growth opportunities in the coming years.

Furthermore, in the Asia Pacific region, increasing health awareness among the population and the rapid market evolution in using new injectable drug delivery systems or technologies are expected to drive market growth during the forecast period. The Chinese and Indian governments are establishing new policies to improve the population's health, including coverage expansion of public healthcare institutions and standardizing their services.

Reasons for buying this report:-

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data & forecasts from 2022 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Pen Needle market is segmented and analyzed as follows:

By Type

• Standard Pen Needles
• Safety Pen Needles

By Length

• 4mm and 5mm
• 6mm and 8mm
• 10mm and 12mm

By Therapy

• Insulin
• Glucagon-like-Peptide-1
• Growth Hormone

By Distribution Channel

• Online
• Offline

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Others
• Middle East and Africa
• UAE
• Saudi Arabia
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Process

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. Analyst View

4. MARKET DYNAMICS

• 4.1. Market Drivers
  • 4.1.1. Growing Demand for Packaging
  • 4.1.2. Increasing Focus on Sustainability
• 4.2. Market Restraints
  • 4.2.1. Environmental Concerns
  • 4.2.2. High Production Cost
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. The Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. PEN NEEDLE MARKET ANALYSIS BY TYPE

• 5.1. Introduction
• 5.2. Standard Pen Needles
• 5.3. Safety Pen Needles

6. PEN NEEDLE MARKET ANALYSIS BY LENGTH

• 6.1. Introduction
• 6.2. 4mm and 5mm
• 6.3. 6mm and 8mm
• 6.4. 10mm and 12mm

7. PEN NEEDLE MARKET ANALYSIS BY THERAPY

• 7.1. Introduction
• 7.2. Insulin
• 7.3. Glucagon-like-Peptide-1
• 7.4. Growth Hormone

8. PEN NEEDLE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 8.1. Introduction
• 8.2. Online
• 8.3. Offline

9. PEN NEEDLE MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. United States
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. UK
  • 9.4.2. Germany
  • 9.4.3. France
  • 9.4.4. Spain
  • 9.4.5. Italy
  • 9.4.6. Others
• 9.5. Middle East and Africa
  • 9.5.1. UAE
  • 9.5.2. Saudi Arabia
  • 9.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. Japan
  • 9.6.2. China
  • 9.6.3. India
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Thailand
  • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Emerging Players and Market Lucrativeness
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES

• 11.1. Becton, Dickinson and Company
• 11.2. Glucorx
• 11.3. Braun Melsungen
• 11.4. Ypsomed
• 11.5. Novo Nordisk
• 11.6. HTL-Strefa
• 11.7. Ultimed, Inc.
• 11.8. Allison Medical, Inc.
• 11.9. Terumo Corporation
• 11.10. Owen Mumford, Ltd.